DM1: Clinical Trials

1 trial for DM1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow DM1: new trials by email Literature Review of DM1 trials Research Report on DM1

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Global Study of Del-desiran for the Treatment of DM1
AOC 1001 (del-desiran), Placebo - DM1, Myotonic Dystrophy
Phase 3CompletedAvidity Biosciences, Inc.1592024-05-302026-09-01

Narrower conditions

Myotonia (1)  ·  Myotonic Disorders (1)  ·  Myotonic Dystrophy (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Muscular Diseases (1)  ·  Muscular Disorders, Atrophic (1)  ·  Muscular Dystrophies (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Avidity Biosciences, Inc. (1)

Countries

Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)